Difficulty: Medium
Average Score: 80%
Practice
Low molecular weight heparins differ from conventional heparin in that
Correct answer
D
Rationale
Low molecular weight heparins (LMWH) differ from conventional heparin in several key aspects, making option D (All of the above) the correct choice.
A) LMWH selectively inhibit factor Xa, which plays a crucial role in the coagulation cascade, unlike conventional heparin which inhibits both factor Xa and thrombin.
B) LMWH do not significantly prolong clotting time compared to conventional heparin. This is because LMWH have a more predictable anticoagulant effect due to their more specific targeting of factor Xa.
C) LMWH are metabolized more slowly and have a longer duration of action compared to conventional heparin. This allows for less frequent dosing and more stable anticoagulant levels, making them more convenient for patients.
Educationally, understanding the differences between LMWH and conventional heparin is essential for healthcare professionals involved in managing patients requiring anticoagulant therapy. This knowledge helps in making informed decisions regarding the selection and monitoring of anticoagulants based on individual patient characteristics and clinical indications.
A) LMWH selectively inhibit factor Xa, which plays a crucial role in the coagulation cascade, unlike conventional heparin which inhibits both factor Xa and thrombin.
B) LMWH do not significantly prolong clotting time compared to conventional heparin. This is because LMWH have a more predictable anticoagulant effect due to their more specific targeting of factor Xa.
C) LMWH are metabolized more slowly and have a longer duration of action compared to conventional heparin. This allows for less frequent dosing and more stable anticoagulant levels, making them more convenient for patients.
Educationally, understanding the differences between LMWH and conventional heparin is essential for healthcare professionals involved in managing patients requiring anticoagulant therapy. This knowledge helps in making informed decisions regarding the selection and monitoring of anticoagulants based on individual patient characteristics and clinical indications.